These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 18799082
1. Anti-cyclic citrullinated peptide antibody in systemic sclerosis. Morita Y, Muro Y, Sugiura K, Tomita Y. Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082 [Abstract] [Full Text] [Related]
3. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Kuwata S, Takeuchi F. Clin Rheumatol; 2010 Mar; 29(3):241-6. PubMed ID: 20091076 [Abstract] [Full Text] [Related]
4. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis. Ryu HJ, Takeuchi F, Kuwata S, Kim YJ, Lee EY, Lee EB, Song YW. Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964 [Abstract] [Full Text] [Related]
5. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Santiago M, Baron M, Miyachi K, Fritzler MJ, Abu-Hakima M, Leclercq S, Bell M, Hudson M, Mathieu JP, Taillefer S, Jones N, Docherty P, Khraishi M, Markland J, Pope J, Robinson D, Smith D, Sutton E. Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008 [Abstract] [Full Text] [Related]
6. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. Ueda-Hayakawa I, Hasegawa M, Kumada S, Tanaka C, Komura K, Hamaguchi Y, Takehara K, Fujimoto M. Rheumatology (Oxford); 2010 Nov; 49(11):2135-9. PubMed ID: 20663814 [Abstract] [Full Text] [Related]
11. [Prevalence of anti-CCP antibodies in systemic sclerosis]. Marrone M, Chialà A, Tampoia M, Iannone F, Raho L, Covelli M, Grattagliano V, Pansini N, Lapadula G. Reumatismo; 2007 Apr; 59(1):20-4. PubMed ID: 17435838 [Abstract] [Full Text] [Related]
13. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis]. Xie QB, Yin G. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016 [Abstract] [Full Text] [Related]
16. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics. Lu MC, Hsieh SC, Lai NS, Li KJ, Wu CH, Yu CL. Clin Exp Rheumatol; 2007 May; 25(5):716-21. PubMed ID: 18078619 [Abstract] [Full Text] [Related]
19. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis. Kamali S, Polat NG, Kasapoglu E, Gul A, Ocal L, Aral O, Konice M, Badur S, Inanc M. Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038 [Abstract] [Full Text] [Related]
20. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]